Thanks for the post BB. I think the good doctor makes a

New Post Public Reply Private Reply Replies (1) Message Board
Ramjet biloxiblues #164337
342
Thanks for the post BB. I think the good doctor makes a good point: as important as the LL trifluridine-tipiracil (TAS-102) and bevacizumab part of the trial is, the rollover protocol is another very important part of the trial. The LL combo ICI part means that the story won't be fully known until the patients on LL plus Keytruda get their results well after January. So this trial will continue after that with many potential success points: LL with backbone, LL alone, PD-L1 upregulation, ctDNA, LL with Keytruda, and so on. 
In addition, there is the City of Hope CHAMP trial, mTNBC EAP, Pre-I-SPY, I-SPY, and the mTnBC phase 2 trial. Plus Alzheimers Phase 2A and HIV baby cure. Plus various studies starting, and the funding to do them all. Many irons in the fire.

Ignore the negative articles written by those with vested interests. My Dad once told me, "Don't believe everything you read," and he is right. With the help of the all mighty, Dr J and team are moving mountains, and they have my full support.

KOKO&SLLH
Thanks, Ramjet  

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

ACE Money Transfer Expands into European Markets from Ireland

Updated Category News Views 141

ACE Money Transfer's European Expansion Journey Ace Money Transfer is embarking on an exciting new adventure by expanding its services into Europe, with Ireland as its strategic base. This initiative aims to reshape the remittance landscape across the continent, building on the company's robust foundation established in Ireland. Why Ireland is the Launchpad for Growth...

Continue Reading
Legal Opportunity for BioAge Labs Investors Awaits Action

Updated Category News Views 90

Investors Prepare for Class Action Against BioAge Labs Investors in BioAge Labs, Inc. (NASDAQ: BIOA) have been alerted to an upcoming opportunity to take part in a securities class action lawsuit. This comes from the Rosen Law Firm, a global advocate for investor rights. The firm is advocating for those who purchased shares of BioAge during its initial public offering...

Continue Reading
Iveda Partners with Data Management to Advance Sustainability

Updated Category News Views 41

Iveda's Strategic Partnership to Enhance Sustainability Iveda, a leader in cloud-based AI technology, is partnering with Data Management, renowned for its expertise in disaster recovery services, to reduce carbon emissions and improve energy efficiency. This collaboration utilizes IvedaEMS, an advanced Energy Management System (EMS) that cleverly employs smart meters to...

Continue Reading
IPSEN Reports on Recent Share Buy-Back Activities in 2025

Updated Category News Views 156

Overview of IPSEN's Share Buy-Back Program IPSEN has been actively engaged in its share buy-back program, which reflects the company's commitment to maximizing shareholder value. The program is a strategic move to enhance EPS and demonstrate confidence in the business's long-term prospects. This article will delve into the specifics of transactions executed during a...

Continue Reading
Turkey's Central Bank Steadfast Amid Inflation Concerns

Updated Category News Views 72

Turkey's Central Bank Stays the Course at 50% Rate Turkey's central bank has opted to keep its policy rate steady at 50%. This decision aligns with market expectations as the institution continues to monitor inflation risks closely. Analysis of Central Bank's Position Following the monetary policy committee meeting, the central bank emphasized that the policy rate would...

Continue Reading